Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
Identifieur interne : 000367 ( Main/Exploration ); précédent : 000366; suivant : 000368Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
Auteurs : Benjamin J. Ridenhour [États-Unis] ; Michael A. Campitelli ; Jeffrey C. Kwong ; Laura C. Rosella ; Ben G. Armstrong ; Punam Mangtani ; Andrew J. Calzavara ; David K. ShaySource :
- PloS one [ 1932-6203 ] ; 2013.
Descripteurs français
- KwdFr :
- Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (mortalité), Hospitalisation (), Humains, Intervalles de confiance, Modèles linéaires, Ontario (épidémiologie), Résultat thérapeutique, Saisons, Sujet âgé, Surveillance de la population, Vaccination (), Vaccins antigrippaux (immunologie), Vaccins inactivés (immunologie).
- MESH :
- immunologie : Grippe humaine, Vaccins antigrippaux, Vaccins inactivés.
- mortalité : Grippe humaine.
- épidémiologie : Ontario.
- Grippe humaine, Hospitalisation, Humains, Intervalles de confiance, Modèles linéaires, Résultat thérapeutique, Saisons, Sujet âgé, Surveillance de la population, Vaccination.
English descriptors
- KwdEn :
- Aged, Confidence Intervals, Hospitalization (statistics & numerical data), Humans, Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (mortality), Influenza, Human (prevention & control), Linear Models, Ontario (epidemiology), Population Surveillance, Seasons, Treatment Outcome, Vaccination (statistics & numerical data), Vaccines, Inactivated (immunology).
- MESH :
- chemical , immunology : Influenza Vaccines, Vaccines, Inactivated.
- geographic , epidemiology : Ontario.
- immunology : Influenza, Human.
- mortality : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Hospitalization, Vaccination.
- Aged, Confidence Intervals, Humans, Linear Models, Population Surveillance, Seasons, Treatment Outcome.
Abstract
BACKGROUND
Estimates of the effectiveness of influenza vaccines in older adults may be biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications.
METHODS
We conducted a retrospective cohort study among Ontario residents aged ≥ 65 years from September 1993 through September 2008. We linked weekly vaccination, hospitalization, and death records for 1.4 million community-dwelling persons aged ≥ 65 years. Vaccine effectiveness was estimated by comparing ratios of outcome rates during weeks of high versus low influenza activity (defined by viral surveillance data) among vaccinated and unvaccinated subjects by using log-linear regression models that accounted for temperature and time trends with natural spline functions. Effectiveness was estimated for three influenza-associated outcomes: all-cause deaths, deaths occurring within 30 days of pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations.
RESULTS
During weeks when 5% of respiratory specimens tested positive for influenza A, vaccine effectiveness among persons aged ≥ 65 years was 22% (95% confidence interval [CI], -6%-42%) for all influenza-associated deaths, 25% (95% CI, 13%-37%) for deaths occurring within 30 days after an influenza-associated pneumonia/influenza hospitalization, and 19% (95% CI, 4%-31%) for influenza-associated pneumonia/influenza hospitalizations. Because small proportions of deaths, deaths after pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations were associated with influenza virus circulation, we estimated that vaccination prevented 1.6%, 4.8%, and 4.1% of these outcomes, respectively.
CONCLUSIONS
By using confounding-reducing techniques with 15 years of provincial-level data including vaccination and health outcomes, we estimated that influenza vaccination prevented ~4% of influenza-associated hospitalizations and deaths occurring after hospitalizations among older adults in Ontario.
DOI: 10.1371/journal.pone.0076318
PubMed: 24146855
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.</title><author><name sortKey="Ridenhour, Benjamin J" sort="Ridenhour, Benjamin J" uniqKey="Ridenhour B" first="Benjamin J" last="Ridenhour">Benjamin J. Ridenhour</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America ; Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, South Bend, Indiana, United States of America.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America ; Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, South Bend, Indiana</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name></author><author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name></author><author><name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name></author><author><name sortKey="Armstrong, Ben G" sort="Armstrong, Ben G" uniqKey="Armstrong B" first="Ben G" last="Armstrong">Ben G. Armstrong</name></author><author><name sortKey="Mangtani, Punam" sort="Mangtani, Punam" uniqKey="Mangtani P" first="Punam" last="Mangtani">Punam Mangtani</name></author><author><name sortKey="Calzavara, Andrew J" sort="Calzavara, Andrew J" uniqKey="Calzavara A" first="Andrew J" last="Calzavara">Andrew J. Calzavara</name></author><author><name sortKey="Shay, David K" sort="Shay, David K" uniqKey="Shay D" first="David K" last="Shay">David K. Shay</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24146855</idno><idno type="pmid">24146855</idno><idno type="doi">10.1371/journal.pone.0076318</idno><idno type="wicri:Area/Main/Corpus">000321</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000321</idno><idno type="wicri:Area/Main/Curation">000321</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000321</idno><idno type="wicri:Area/Main/Exploration">000321</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.</title><author><name sortKey="Ridenhour, Benjamin J" sort="Ridenhour, Benjamin J" uniqKey="Ridenhour B" first="Benjamin J" last="Ridenhour">Benjamin J. Ridenhour</name><affiliation wicri:level="2"><nlm:affiliation>Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America ; Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, South Bend, Indiana, United States of America.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America ; Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, South Bend, Indiana</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name></author><author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name></author><author><name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name></author><author><name sortKey="Armstrong, Ben G" sort="Armstrong, Ben G" uniqKey="Armstrong B" first="Ben G" last="Armstrong">Ben G. Armstrong</name></author><author><name sortKey="Mangtani, Punam" sort="Mangtani, Punam" uniqKey="Mangtani P" first="Punam" last="Mangtani">Punam Mangtani</name></author><author><name sortKey="Calzavara, Andrew J" sort="Calzavara, Andrew J" uniqKey="Calzavara A" first="Andrew J" last="Calzavara">Andrew J. Calzavara</name></author><author><name sortKey="Shay, David K" sort="Shay, David K" uniqKey="Shay D" first="David K" last="Shay">David K. Shay</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Confidence Intervals</term><term>Hospitalization (statistics & numerical data)</term><term>Humans</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (mortality)</term><term>Influenza, Human (prevention & control)</term><term>Linear Models</term><term>Ontario (epidemiology)</term><term>Population Surveillance</term><term>Seasons</term><term>Treatment Outcome</term><term>Vaccination (statistics & numerical data)</term><term>Vaccines, Inactivated (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (mortalité)</term><term>Hospitalisation ()</term><term>Humains</term><term>Intervalles de confiance</term><term>Modèles linéaires</term><term>Ontario (épidémiologie)</term><term>Résultat thérapeutique</term><term>Saisons</term><term>Sujet âgé</term><term>Surveillance de la population</term><term>Vaccination ()</term><term>Vaccins antigrippaux (immunologie)</term><term>Vaccins inactivés (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Inactivated</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Vaccins antigrippaux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ontario</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Confidence Intervals</term><term>Humans</term><term>Linear Models</term><term>Population Surveillance</term><term>Seasons</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Grippe humaine</term><term>Hospitalisation</term><term>Humains</term><term>Intervalles de confiance</term><term>Modèles linéaires</term><term>Résultat thérapeutique</term><term>Saisons</term><term>Sujet âgé</term><term>Surveillance de la population</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Estimates of the effectiveness of influenza vaccines in older adults may be biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We conducted a retrospective cohort study among Ontario residents aged ≥ 65 years from September 1993 through September 2008. We linked weekly vaccination, hospitalization, and death records for 1.4 million community-dwelling persons aged ≥ 65 years. Vaccine effectiveness was estimated by comparing ratios of outcome rates during weeks of high versus low influenza activity (defined by viral surveillance data) among vaccinated and unvaccinated subjects by using log-linear regression models that accounted for temperature and time trends with natural spline functions. Effectiveness was estimated for three influenza-associated outcomes: all-cause deaths, deaths occurring within 30 days of pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>During weeks when 5% of respiratory specimens tested positive for influenza A, vaccine effectiveness among persons aged ≥ 65 years was 22% (95% confidence interval [CI], -6%-42%) for all influenza-associated deaths, 25% (95% CI, 13%-37%) for deaths occurring within 30 days after an influenza-associated pneumonia/influenza hospitalization, and 19% (95% CI, 4%-31%) for influenza-associated pneumonia/influenza hospitalizations. Because small proportions of deaths, deaths after pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations were associated with influenza virus circulation, we estimated that vaccination prevented 1.6%, 4.8%, and 4.1% of these outcomes, respectively.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>By using confounding-reducing techniques with 15 years of provincial-level data including vaccination and health outcomes, we estimated that influenza vaccination prevented ~4% of influenza-associated hospitalizations and deaths occurring after hospitalizations among older adults in Ontario.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24146855</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>10</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.</ArticleTitle><Pagination><MedlinePgn>e76318</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0076318</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Estimates of the effectiveness of influenza vaccines in older adults may be biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study among Ontario residents aged ≥ 65 years from September 1993 through September 2008. We linked weekly vaccination, hospitalization, and death records for 1.4 million community-dwelling persons aged ≥ 65 years. Vaccine effectiveness was estimated by comparing ratios of outcome rates during weeks of high versus low influenza activity (defined by viral surveillance data) among vaccinated and unvaccinated subjects by using log-linear regression models that accounted for temperature and time trends with natural spline functions. Effectiveness was estimated for three influenza-associated outcomes: all-cause deaths, deaths occurring within 30 days of pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During weeks when 5% of respiratory specimens tested positive for influenza A, vaccine effectiveness among persons aged ≥ 65 years was 22% (95% confidence interval [CI], -6%-42%) for all influenza-associated deaths, 25% (95% CI, 13%-37%) for deaths occurring within 30 days after an influenza-associated pneumonia/influenza hospitalization, and 19% (95% CI, 4%-31%) for influenza-associated pneumonia/influenza hospitalizations. Because small proportions of deaths, deaths after pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations were associated with influenza virus circulation, we estimated that vaccination prevented 1.6%, 4.8%, and 4.1% of these outcomes, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">By using confounding-reducing techniques with 15 years of provincial-level data including vaccination and health outcomes, we estimated that influenza vaccination prevented ~4% of influenza-associated hospitalizations and deaths occurring after hospitalizations among older adults in Ontario.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ridenhour</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America ; Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, South Bend, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campitelli</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Jeffrey C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Rosella</LastName><ForeName>Laura C</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Ben G</ForeName><Initials>BG</Initials></Author><Author ValidYN="Y"><LastName>Mangtani</LastName><ForeName>Punam</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Calzavara</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Shay</LastName><ForeName>David K</ForeName><Initials>DK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>04</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>08</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24146855</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0076318</ArticleId><ArticleId IdType="pii">PONE-D-13-17688</ArticleId><ArticleId IdType="pmc">PMC3797825</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Intern Med. 2005 Feb 14;165(3):265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15710788</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Public Health. 1998;19:17-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9611610</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2006 Mar 1;42(5):640-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16447109</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Public Health. 2006;27:57-79</Citation><ArticleIdList><ArticleId IdType="pubmed">16533109</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):345-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16368724</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">16368725</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Jan 26;25(7):1270-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17079057</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2007 Jan 17;297(3):278-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17227979</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2007 Oct;135(7):1109-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17306052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2007 Oct;7(10):658-66</Citation><ArticleIdList><ArticleId IdType="pubmed">17897608</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Oct 4;357(14):1373-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17914038</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Aug 2;372(9636):398-405</Citation><ArticleIdList><ArticleId IdType="pubmed">18675690</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 2008 Jul;34(ACS-3):1-46</Citation><ArticleIdList><ArticleId IdType="pubmed">18802991</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2008 Oct 28;5(10):e211</Citation><ArticleIdList><ArticleId IdType="pubmed">18959473</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Mar 18;27(13):1923-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19368772</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19644442</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2009 Sep 1;170(5):650-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19625341</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2009 Oct 13;181(8):484-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19770237</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009;4(11):e8087</Citation><ArticleIdList><ArticleId IdType="pubmed">19956645</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Dec 11;28(2):379-85</Citation><ArticleIdList><ArticleId IdType="pubmed">19879222</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 2010 May;21(3):383-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Oct 21;28(45):7267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">20832494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Dec 16;29(2):240-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21044667</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Apr 1;52(7):911-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21427399</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2012 Mar 26;172(6):484-91</Citation><ArticleIdList><ArticleId IdType="pubmed">22371873</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 2013 Jul;24(4):530-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23732734</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp Q. 1999-2000 Winter;3(2):17</Citation><ArticleIdList><ArticleId IdType="pubmed">11570359</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation><ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2004 Jul 1;190(1):1-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15195237</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Sep 15;292(11):1333-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15367555</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2004 Sep 18;329(7467):660</Citation><ArticleIdList><ArticleId IdType="pubmed">15313884</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1986 Jul;24(1):157-60</Citation><ArticleIdList><ArticleId IdType="pubmed">3722363</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 1987 Aug;99(1):65-84</Citation><ArticleIdList><ArticleId IdType="pubmed">3609175</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Dec 7;272(21):1661-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7966893</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1994 Oct;12(13):1185-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7839722</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1997 Dec;87(12):1944-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9431281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Oct 1;366(9492):1165-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16198765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Indiana</li></region></list><tree><noCountry><name sortKey="Armstrong, Ben G" sort="Armstrong, Ben G" uniqKey="Armstrong B" first="Ben G" last="Armstrong">Ben G. Armstrong</name><name sortKey="Calzavara, Andrew J" sort="Calzavara, Andrew J" uniqKey="Calzavara A" first="Andrew J" last="Calzavara">Andrew J. Calzavara</name><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name><name sortKey="Mangtani, Punam" sort="Mangtani, Punam" uniqKey="Mangtani P" first="Punam" last="Mangtani">Punam Mangtani</name><name sortKey="Rosella, Laura C" sort="Rosella, Laura C" uniqKey="Rosella L" first="Laura C" last="Rosella">Laura C. Rosella</name><name sortKey="Shay, David K" sort="Shay, David K" uniqKey="Shay D" first="David K" last="Shay">David K. Shay</name></noCountry><country name="États-Unis"><region name="Indiana"><name sortKey="Ridenhour, Benjamin J" sort="Ridenhour, Benjamin J" uniqKey="Ridenhour B" first="Benjamin J" last="Ridenhour">Benjamin J. Ridenhour</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000367 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000367 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24146855
|texte= Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24146855" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |